ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 132 filers reported holding ENDOLOGIX INC in Q1 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $77,000 | -47.3% | 106,979 | +40.2% | 0.00% | – |
| Q3 2018 | $146,000 | -68.5% | 76,278 | -6.7% | 0.00% | -100.0% |
| Q2 2018 | $463,000 | +41.2% | 81,728 | +5.3% | 0.00% | 0.0% |
| Q1 2018 | $328,000 | -25.5% | 77,608 | -5.7% | 0.00% | 0.0% |
| Q4 2017 | $440,000 | +1.9% | 82,258 | -15.1% | 0.00% | 0.0% |
| Q3 2017 | $432,000 | -7.1% | 96,866 | +1.3% | 0.00% | 0.0% |
| Q2 2017 | $465,000 | -32.5% | 95,581 | +0.4% | 0.00% | -50.0% |
| Q1 2017 | $689,000 | +30.5% | 95,200 | +3.1% | 0.00% | +100.0% |
| Q4 2016 | $528,000 | -51.2% | 92,311 | +9.3% | 0.00% | -66.7% |
| Q3 2016 | $1,082,000 | +3.2% | 84,493 | +0.4% | 0.00% | 0.0% |
| Q2 2016 | $1,048,000 | +64.8% | 84,133 | +10.6% | 0.00% | +50.0% |
| Q1 2016 | $636,000 | -9.1% | 76,048 | +7.6% | 0.00% | 0.0% |
| Q4 2015 | $700,000 | -11.7% | 70,693 | +9.3% | 0.00% | -33.3% |
| Q3 2015 | $793,000 | -20.7% | 64,693 | -0.8% | 0.00% | 0.0% |
| Q2 2015 | $1,000,000 | -12.0% | 65,204 | -2.1% | 0.00% | 0.0% |
| Q1 2015 | $1,137,000 | +26.2% | 66,589 | +13.0% | 0.00% | 0.0% |
| Q4 2014 | $901,000 | +42.6% | 58,939 | -1.1% | 0.00% | +50.0% |
| Q3 2014 | $632,000 | -29.0% | 59,589 | +1.9% | 0.00% | -33.3% |
| Q2 2014 | $890,000 | +13.5% | 58,489 | -4.0% | 0.00% | +50.0% |
| Q1 2014 | $784,000 | -29.7% | 60,927 | -4.8% | 0.00% | -33.3% |
| Q4 2013 | $1,116,000 | +7.4% | 63,997 | -0.7% | 0.00% | 0.0% |
| Q3 2013 | $1,039,000 | +20.1% | 64,437 | -1.0% | 0.00% | 0.0% |
| Q2 2013 | $865,000 | – | 65,108 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|